Iwatate, Yosuke
Hoshino, Isamu
Yokota, Hajime
Ishige, Fumitaka
Itami, Makiko
Mori, Yasukuni
Chiba, Satoshi
Arimitsu, Hidehito
Yanagibashi, Hiroo
Nagase, Hiroki
Takayama, Wataru
Article History
Received: 15 March 2020
Revised: 21 June 2020
Accepted: 29 June 2020
First Online: 21 July 2020
Ethics approval and consent to participate
: This study was approved by the Chiba Cancer Center Review Board (H29-006). All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation and with the Helsinki Declaration of 1964 and its later amendments. Informed consent was obtained from all patients in this study.
: Written informed consent was obtained from the patients for publication of this study and accompanying clinicopathological data.
: The data that support the findings of this study are available from the corresponding author upon reasonable request.
: The authors declare no competing interests.
: Funding information is not applicable.